[
  {
    "id": "fc_ph_group3_d50c0839",
    "front": "CT for LAM diagnosis?",
    "back": "Not used in isolation.",
    "difficulty": "easy",
    "cardType": "definition",
    "conceptTags": [],
    "topic": "Group 3 PH (Due to Lung Disease)",
    "bookId": "ph_group3",
    "sourceSection": "Hemodynamic Definition of PH Based on the 6th World Symposium on Pulmonary Hypertension",
    "sourceLocation": {
      "bookName": "MurrayNadel_Section_10_OCR",
      "chapter": "1140 PART 3 ⚫ Clinical Respiratory Medicine",
      "section": "Hemodynamic Definition of PH Based on the 6th World Symposium on Pulmonary Hypertension",
      "pageNumber": 64
    }
  },
  {
    "id": "fc_ph_group3_67f2fe8f",
    "front": "Specific LAM diagnostic biomarker?",
    "back": "Serum VEGF-D.",
    "difficulty": "easy",
    "cardType": "definition",
    "conceptTags": [],
    "topic": "Group 3 PH (Due to Lung Disease)",
    "bookId": "ph_group3",
    "sourceSection": "Hemodynamic Definition of PH Based on the 6th World Symposium on Pulmonary Hypertension",
    "sourceLocation": {
      "bookName": "MurrayNadel_Section_10_OCR",
      "chapter": "1140 PART 3 ⚫ Clinical Respiratory Medicine",
      "section": "Hemodynamic Definition of PH Based on the 6th World Symposium on Pulmonary Hypertension",
      "pageNumber": 64
    }
  },
  {
    "id": "fc_ph_group3_3058c459",
    "front": "Trans-bronchial LAM biopsy yield?",
    "back": ">50% diagnostic yield.",
    "difficulty": "moderate",
    "cardType": "definition",
    "conceptTags": [],
    "topic": "Group 3 PH (Due to Lung Disease)",
    "bookId": "ph_group3",
    "sourceSection": "Hemodynamic Definition of PH Based on the 6th World Symposium on Pulmonary Hypertension",
    "sourceLocation": {
      "bookName": "MurrayNadel_Section_10_OCR",
      "chapter": "1140 PART 3 ⚫ Clinical Respiratory Medicine",
      "section": "Hemodynamic Definition of PH Based on the 6th World Symposium on Pulmonary Hypertension",
      "pageNumber": 64
    }
  },
  {
    "id": "fc_ph_group3_4d57338c",
    "front": "First-line LAM treatment?",
    "back": "Sirolimus.",
    "difficulty": "easy",
    "cardType": "definition",
    "conceptTags": [],
    "topic": "Group 3 PH (Due to Lung Disease)",
    "bookId": "ph_group3",
    "sourceSection": "Hemodynamic Definition of PH Based on the 6th World Symposium on Pulmonary Hypertension",
    "sourceLocation": {
      "bookName": "MurrayNadel_Section_10_OCR",
      "chapter": "1140 PART 3 ⚫ Clinical Respiratory Medicine",
      "section": "Hemodynamic Definition of PH Based on the 6th World Symposium on Pulmonary Hypertension",
      "pageNumber": 64
    }
  },
  {
    "id": "fc_ph_group3_1e089093",
    "front": "Hormonal agents for LAM?",
    "back": "Not routinely used.",
    "difficulty": "easy",
    "cardType": "definition",
    "conceptTags": [],
    "topic": "Group 3 PH (Due to Lung Disease)",
    "bookId": "ph_group3",
    "sourceSection": "Hemodynamic Definition of PH Based on the 6th World Symposium on Pulmonary Hypertension",
    "sourceLocation": {
      "bookName": "MurrayNadel_Section_10_OCR",
      "chapter": "1140 PART 3 ⚫ Clinical Respiratory Medicine",
      "section": "Hemodynamic Definition of PH Based on the 6th World Symposium on Pulmonary Hypertension",
      "pageNumber": 64
    }
  },
  {
    "id": "fc_ph_group3_651ed06c",
    "front": "LAM diagnosis: CT findings alone?",
    "back": "No, CT should not be used in isolation.",
    "difficulty": "easy",
    "cardType": "definition",
    "conceptTags": [],
    "topic": "Group 3 PH (Due to Lung Disease)",
    "bookId": "ph_group3",
    "sourceSection": "Hemodynamic Definition of PH Based on the 6th World Symposium on Pulmonary Hypertension",
    "sourceLocation": {
      "bookName": "MurrayNadel_Section_10_OCR",
      "chapter": "1140 PART 3 ⚫ Clinical Respiratory Medicine",
      "section": "Hemodynamic Definition of PH Based on the 6th World Symposium on Pulmonary Hypertension",
      "pageNumber": 64
    }
  },
  {
    "id": "fc_ph_group3_87ca7d26",
    "front": "LAM: Highly specific diagnostic biomarker?",
    "back": "Serum VEGF-D.",
    "difficulty": "easy",
    "cardType": "definition",
    "conceptTags": [],
    "topic": "Group 3 PH (Due to Lung Disease)",
    "bookId": "ph_group3",
    "sourceSection": "Hemodynamic Definition of PH Based on the 6th World Symposium on Pulmonary Hypertension",
    "sourceLocation": {
      "bookName": "MurrayNadel_Section_10_OCR",
      "chapter": "1140 PART 3 ⚫ Clinical Respiratory Medicine",
      "section": "Hemodynamic Definition of PH Based on the 6th World Symposium on Pulmonary Hypertension",
      "pageNumber": 64
    }
  },
  {
    "id": "fc_ph_group3_bc94823d",
    "front": "Trans-bronchial biopsy yield for LAM?",
    "back": ">50% diagnostic yield.",
    "difficulty": "easy",
    "cardType": "definition",
    "conceptTags": [],
    "topic": "Group 3 PH (Due to Lung Disease)",
    "bookId": "ph_group3",
    "sourceSection": "Hemodynamic Definition of PH Based on the 6th World Symposium on Pulmonary Hypertension",
    "sourceLocation": {
      "bookName": "MurrayNadel_Section_10_OCR",
      "chapter": "1140 PART 3 ⚫ Clinical Respiratory Medicine",
      "section": "Hemodynamic Definition of PH Based on the 6th World Symposium on Pulmonary Hypertension",
      "pageNumber": 64
    }
  },
  {
    "id": "fc_ph_group3_80aceb07",
    "front": "LAM treatment: Hormonal agents routinely?",
    "back": "No, not routinely used.",
    "difficulty": "easy",
    "cardType": "definition",
    "conceptTags": [],
    "topic": "Group 3 PH (Due to Lung Disease)",
    "bookId": "ph_group3",
    "sourceSection": "Hemodynamic Definition of PH Based on the 6th World Symposium on Pulmonary Hypertension",
    "sourceLocation": {
      "bookName": "MurrayNadel_Section_10_OCR",
      "chapter": "1140 PART 3 ⚫ Clinical Respiratory Medicine",
      "section": "Hemodynamic Definition of PH Based on the 6th World Symposium on Pulmonary Hypertension",
      "pageNumber": 64
    }
  },
  {
    "id": "fc_ph_group3_9a5cfd5f",
    "front": "LAM: First-line pharmacologic treatment?",
    "back": "Sirolimus.",
    "difficulty": "easy",
    "cardType": "definition",
    "conceptTags": [],
    "topic": "Group 3 PH (Due to Lung Disease)",
    "bookId": "ph_group3",
    "sourceSection": "Hemodynamic Definition of PH Based on the 6th World Symposium on Pulmonary Hypertension",
    "sourceLocation": {
      "bookName": "MurrayNadel_Section_10_OCR",
      "chapter": "1140 PART 3 ⚫ Clinical Respiratory Medicine",
      "section": "Hemodynamic Definition of PH Based on the 6th World Symposium on Pulmonary Hypertension",
      "pageNumber": 64
    }
  },
  {
    "id": "fc_ph_group3_2bb761a1",
    "front": "LAM diagnosis: HRCT alone?",
    "back": "No, not in isolation.",
    "difficulty": "easy",
    "cardType": "definition",
    "conceptTags": [],
    "topic": "Group 3 PH (Due to Lung Disease)",
    "bookId": "ph_group3",
    "sourceSection": "Hemodynamic Definition of PH Based on the 6th World Symposium on Pulmonary Hypertension",
    "sourceLocation": {
      "bookName": "MurrayNadel_Section_10_OCR",
      "chapter": "1140 PART 3 ⚫ Clinical Respiratory Medicine",
      "section": "Hemodynamic Definition of PH Based on the 6th World Symposium on Pulmonary Hypertension",
      "pageNumber": 64
    }
  },
  {
    "id": "fc_ph_group3_2b03cbba",
    "front": "LAM specific diagnostic biomarker?",
    "back": "Serum VEGF-D.",
    "difficulty": "easy",
    "cardType": "definition",
    "conceptTags": [],
    "topic": "Group 3 PH (Due to Lung Disease)",
    "bookId": "ph_group3",
    "sourceSection": "Hemodynamic Definition of PH Based on the 6th World Symposium on Pulmonary Hypertension",
    "sourceLocation": {
      "bookName": "MurrayNadel_Section_10_OCR",
      "chapter": "1140 PART 3 ⚫ Clinical Respiratory Medicine",
      "section": "Hemodynamic Definition of PH Based on the 6th World Symposium on Pulmonary Hypertension",
      "pageNumber": 64
    }
  },
  {
    "id": "fc_ph_group3_e80eb717",
    "front": "LAM trans-bronchial biopsy diagnostic yield?",
    "back": ">50%.",
    "difficulty": "easy",
    "cardType": "definition",
    "conceptTags": [],
    "topic": "Group 3 PH (Due to Lung Disease)",
    "bookId": "ph_group3",
    "sourceSection": "Hemodynamic Definition of PH Based on the 6th World Symposium on Pulmonary Hypertension",
    "sourceLocation": {
      "bookName": "MurrayNadel_Section_10_OCR",
      "chapter": "1140 PART 3 ⚫ Clinical Respiratory Medicine",
      "section": "Hemodynamic Definition of PH Based on the 6th World Symposium on Pulmonary Hypertension",
      "pageNumber": 64
    }
  },
  {
    "id": "fc_ph_group3_234f6233",
    "front": "LAM: Hormonal agents or Doxycycline?",
    "back": "Not routinely used.",
    "difficulty": "easy",
    "cardType": "definition",
    "conceptTags": [],
    "topic": "Group 3 PH (Due to Lung Disease)",
    "bookId": "ph_group3",
    "sourceSection": "Hemodynamic Definition of PH Based on the 6th World Symposium on Pulmonary Hypertension",
    "sourceLocation": {
      "bookName": "MurrayNadel_Section_10_OCR",
      "chapter": "1140 PART 3 ⚫ Clinical Respiratory Medicine",
      "section": "Hemodynamic Definition of PH Based on the 6th World Symposium on Pulmonary Hypertension",
      "pageNumber": 64
    }
  },
  {
    "id": "fc_ph_group3_0b053bfa",
    "front": "LAM first-line pharmacologic treatment?",
    "back": "Sirolimus.",
    "difficulty": "easy",
    "cardType": "definition",
    "conceptTags": [],
    "topic": "Group 3 PH (Due to Lung Disease)",
    "bookId": "ph_group3",
    "sourceSection": "Hemodynamic Definition of PH Based on the 6th World Symposium on Pulmonary Hypertension",
    "sourceLocation": {
      "bookName": "MurrayNadel_Section_10_OCR",
      "chapter": "1140 PART 3 ⚫ Clinical Respiratory Medicine",
      "section": "Hemodynamic Definition of PH Based on the 6th World Symposium on Pulmonary Hypertension",
      "pageNumber": 64
    }
  }
]